Previous 10 | Next 10 |
The end of the year is fast approaching. And for investors, several things are worth keeping an eye on between now and December. The presidential race is one example. The results of the November elections in the U.S. could affect the market -- positively or otherwise. Another race to pay at...
Vaxart (VXRT) and Centaur Biopharmaceutical Services, a subsidiary of Kindred Biosciences (KIN) have expanded their agreement under which Centaur will manufacture Vaxart's oral vaccine for COVID-19 and other vaccine candidates. Centaur is a full-service contract development and manufacturing ...
Centaur Biopharmaceutical Services Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates PR Newswire SAN FRANCISCO, Oct. 7, 2020 SAN FRANCISCO , Oct. 7, 2020 /PRNewswire/ -- Centaur Biopharmaceutical Services Inc...
Kindred Biosciences Announces Expansion of Manufacturing Agreement with Vaxart for COVID-19 and Other Vaccine Candidates PR Newswire SAN FRANCISCO, Oct. 7, 2020 SAN FRANCISCO , Oct. 7, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmac...
SAN FRANCISCO, CA / ACCESSWIRE / October 6, 2020 / Hagens Berman updates investors in the following publicly-traded companies and urges investors who have suffered significant losses to contact the firm. Further details about the cases, including upcoming application deadlines, can be foun...
VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Vaxart, Inc. - VXRT VAXART INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officer...
Nano-X Imaging (NNOX +25% as company plans to demonstrate its Nanox-ARC system at RSNA 2020.DPW Holdings (DPW +25% after its business launches hybrid EV charger.IDT Corporation (IDT) +18% on Q4 results.Chembio Diagnostics (CEMI +15% on FDA approval for DPP H...
Mike talks about his time at Relational Investors as part of a (mostly) friendly activist operation, his transition to tech and his substack. Mike is a corporate governance ninja who knows exactly how to read the subtle signs included in proxy and other obscure filings. He also ta...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Vaxart, Inc. (NasdaqGS: VXRT). In early 2020, the Company, which focuses on vaccina...
Shares of the clinical-stage biotech Vaxart (NASDAQ: VXRT) slid by as much as 11.3% in early-morning action Wednesday. The developmental vaccine company's shares appear to be reacting negatively to the news that Johnson & Johnson (NYSE: JNJ) has advanced its single-shot ...
News, Short Squeeze, Breakout and More Instantly...
— Cash runway extended into 2026 — — Received one of the largest BARDA-funded Project NextGen Awards to date, up to $453 million — — Company well-capitalized to execute on multiple key clinical and regulatory milestones in COVID-19 and noroviru...
A look at the top 10 most actives in the United States SRIVARU Holding Limited (SVMH) rose 94.8% to $0.2971 on volume of 77,516,058 shares NVIDIA Corporation (NVDA) fell 0.3% to $129.16 on volume of 39,120,242 shares Longeveron Inc. (LGVN) rose 27.0% to $3.415 on volume of 36,214,736 shar...
SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- Vaxart, Inc. (“Vaxart”) (Nasdaq: VXRT) today announced an underwritten offering of 50,000,000 shares of its common stock at an offering price of $0.80 per share, which is a premium to the last closing price of $0.75 per ...